Home   >  
Neuro Signaling Pathway
  >  
Monoamine Oxidase

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

Monoamine Oxidase

Chemical Structure Cat. No. Product Name CAS No.
PXS5505 HCl Chemical Structure
BCP39659 PXS5505 HCl 2409964-23-2
LOX-IN-3 dihydrochloride is an orally active lysyl oxidase (LOX) inhibitor. LOX-IN-3 dihydrochloride can be used for fibrosis, cancer and angiogenesis research.
Lazabemide hydrochloride Chemical Structure
BCP48943 Lazabemide hydrochloride 103878-83-7
Lazabemide hydrochloride is a selective, reversible monoamine oxidase B (MAO-B) inhibitor (IC50 values are 0.03 and > 100 μM for MAO-B and MAO-A respectively). Inhibits monoamine uptake at high concentrations (IC50 values are 86, 123 and > 500 μM for noradrenalin, serotonin and dopamine uptake respectively).
MAO-B-IN-2 Chemical Structure
BCP46491 MAO-B-IN-2 1253978-24-3
MAO-B-IN-2 is a selective and competitive inhibitor of MAO-B and BChE with IC50 values of 0.51 and 7.00 μM, respectively.
Phenelzine Sulfate Chemical Structure
BCP44466 Phenelzine Sulfate 156-51-4
Phenelzine Sulfate is a hydrazine derivative and a potent non-selective monoamine oxidase (MAO) inhibitor with anxiolytic and antidepressant properties.
Contezolid Chemical Structure
BCP42163 Contezolid 1112968-42-9
Contezolid is a monoamine oxidase-A (MAO-A) Inhibitor potentially for the treatment of acute bacterial skin.
Selegiline hydrochloride Chemical Structure
BCP38874 Selegiline hydrochloride 14611-52-0
Selegiline hydrochloride is a selective, irreversible inhibitor of Type B monoamine oxidase. It is used in newly diagnosed patients with Parkinson's disease. It may slow progression of the clinical disease and delay the requirement for levodopa therapy. It also may be given with levodopa upon onset of disability.
PF 9601N Chemical Structure
BCP37785 PF 9601N 133845-63-3
PF 9601N is a selective and potent monoamine oxidase B inhibitor that exhibit anti-Parkinsonian effects in several models of PD.
PXS-5153A dihydrochloride Chemical Structure
BCP36149 PXS-5153A dihydrochloride 2125956-82-1
PXS-5153A is a novel mechanism based, fast-acting, dual LOXL2/LOXL3 inhibitor, which was used to interrogate the role of these enzymes in models of collagen crosslinking and fibrosis.
Tranylcipromine Chemical Structure
BCP35142 Tranylcipromine 155-09-9
Tranylcypromine, an amphetamine derivative, has been found to be a MAO inhibitor that could be used an antidepressant agent and anxiolytic drug.
Toloxatone Chemical Structure
BCP32681 Toloxatone 29218-27-7
Toloxatone is a reversible monoamine oxidase A (MAOA) inhibitor. Antidepressant.
123下一页共 29 条记录 1 / 3 页 
0086-13720134139